Cargando…

Lung surfactant in subacute pulmonary disease

Pulmonary surfactant is a surface active material composed of both lipids and proteins that is produced by alveolar type II pneumocytes. Abnormalities of surfactant in the immature lung or in the acutely inflamed mature lung are well described. However, in a variety of subacute diseases of the matur...

Descripción completa

Detalles Bibliográficos
Autores principales: Devendra, Gehan, Spragg, Roger G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107848/
https://www.ncbi.nlm.nih.gov/pubmed/11980588
http://dx.doi.org/10.1186/rr168
_version_ 1782120220956033024
author Devendra, Gehan
Spragg, Roger G
author_facet Devendra, Gehan
Spragg, Roger G
author_sort Devendra, Gehan
collection PubMed
description Pulmonary surfactant is a surface active material composed of both lipids and proteins that is produced by alveolar type II pneumocytes. Abnormalities of surfactant in the immature lung or in the acutely inflamed mature lung are well described. However, in a variety of subacute diseases of the mature lung, abnormalities of lung surfactant may also be of importance. These diseases include chronic obstructive pulmonary disease, asthma, cystic fibrosis, interstitial lung disease, pneumonia, and alveolar proteinosis. Understanding of the mechanisms that disturb the lung surfactant system may lead to novel rational therapies for these diseases.
format Text
id pubmed-107848
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1078482002-05-09 Lung surfactant in subacute pulmonary disease Devendra, Gehan Spragg, Roger G Respir Res Review Pulmonary surfactant is a surface active material composed of both lipids and proteins that is produced by alveolar type II pneumocytes. Abnormalities of surfactant in the immature lung or in the acutely inflamed mature lung are well described. However, in a variety of subacute diseases of the mature lung, abnormalities of lung surfactant may also be of importance. These diseases include chronic obstructive pulmonary disease, asthma, cystic fibrosis, interstitial lung disease, pneumonia, and alveolar proteinosis. Understanding of the mechanisms that disturb the lung surfactant system may lead to novel rational therapies for these diseases. BioMed Central 2002 2002-04-04 /pmc/articles/PMC107848/ /pubmed/11980588 http://dx.doi.org/10.1186/rr168 Text en Copyright © 2002 BioMed Central Ltd
spellingShingle Review
Devendra, Gehan
Spragg, Roger G
Lung surfactant in subacute pulmonary disease
title Lung surfactant in subacute pulmonary disease
title_full Lung surfactant in subacute pulmonary disease
title_fullStr Lung surfactant in subacute pulmonary disease
title_full_unstemmed Lung surfactant in subacute pulmonary disease
title_short Lung surfactant in subacute pulmonary disease
title_sort lung surfactant in subacute pulmonary disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107848/
https://www.ncbi.nlm.nih.gov/pubmed/11980588
http://dx.doi.org/10.1186/rr168
work_keys_str_mv AT devendragehan lungsurfactantinsubacutepulmonarydisease
AT spraggrogerg lungsurfactantinsubacutepulmonarydisease